Literature DB >> 23681271

Antibiotic prescription practices for pneumonia, skin and soft tissue infections and urinary tract infections throughout the US Veterans Affairs system.

Benedikt Huttner1, Makoto Jones, Angela Huttner, Michael Rubin, Matthew H Samore.   

Abstract

OBJECTIVES: Currently used metrics for antibiotic utilization are not linked to a diagnosis and may be difficult to interpret. We aimed to describe patterns and variation in antibiotic management of three common infectious disease diagnoses in Veterans Affairs Medical Centers (VAMCs).
METHODS: This descriptive retrospective cohort study included all veterans discharged between 2007 and 2009 after an acute care admission to a VAMC and a principal ICD-9-CM code for pneumonia (PNEU), skin and soft-tissue infections (SSTI), urinary tract infections (UTI) or non-infectious disease-related diagnoses (NON_INF). Systemic antibiotic use was assessed based on barcode medication administration data. A treatment period was defined as a time of uninterrupted inpatient antibiotic therapy with no gaps of >1 calendar day.
RESULTS: Over the study period there were 1.44 million discharges with an acute care admission to 128 VAMCs included in the study. Of the discharges, 58 118 had a primary ICD-9-CM diagnosis classifiable as PNEU, 36 797 as SSTI, 30 223 as UTI and 1 243 098 as NON_INF. Empirical antibiotic use during the first 2 hospital days was frequent for all infectious disease diagnoses. Type of empirical coverage varied among facilities for all conditions, as did treatment durations. Roughly half of all empirical courses of therapy where the patient was still hospitalized on day 4 did not exhibit any change to the antibiotic regimen.
CONCLUSIONS: There is substantial variation in the management of common infectious diseases with regard to choice of empirical agents and duration of therapy. Diagnosis-specific antibiotic use metrics may prove useful for antibiotic stewardship programmes.

Entities:  

Keywords:  antibiotic use; infectious disease; practice variation

Mesh:

Substances:

Year:  2013        PMID: 23681271     DOI: 10.1093/jac/dkt171

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  13 in total

1.  Epidemiology and predictors of multidrug-resistant community-acquired and health care-associated pneumonia.

Authors:  Alan E Gross; Trevor C Van Schooneveld; Keith M Olsen; Mark E Rupp; Thu Hong Bui; Elsie Forsung; Andre C Kalil
Journal:  Antimicrob Agents Chemother       Date:  2014-06-23       Impact factor: 5.191

2.  Decreases in Antimicrobial Use Associated With Multihospital Implementation of Electronic Antimicrobial Stewardship Tools.

Authors:  Christopher J Graber; Makoto M Jones; Matthew Bidwell Goetz; Karl Madaras-Kelly; Yue Zhang; Jorie M Butler; Charlene Weir; Ann F Chou; Sarah Y Youn; Matthew H Samore; Peter A Glassman
Journal:  Clin Infect Dis       Date:  2020-08-22       Impact factor: 9.079

3.  National trends in the treatment of urinary tract infections among Veterans' Affairs Community Living Center residents.

Authors:  Haley J Appaneal; Aisling R Caffrey; Vrishali V Lopes; Christopher J Crnich; David M Dosa; Kerry L LaPlante
Journal:  Infect Control Hosp Epidemiol       Date:  2019-07-29       Impact factor: 3.254

4.  Do Patients with Cellulitis Need to be Hospitalized? A Systematic Review and Meta-analysis of Mortality Rates of Inpatients with Cellulitis.

Authors:  Craig G Gunderson; Benjamin M Cherry; Ann Fisher
Journal:  J Gen Intern Med       Date:  2018-07-18       Impact factor: 5.128

5.  Shorter Versus Longer Courses of Antibiotics for Infection in Hospitalized Patients: A Systematic Review and Meta-Analysis.

Authors:  Stephanie Royer; Kimberley M DeMerle; Robert P Dickson; Hallie C Prescott
Journal:  J Hosp Med       Date:  2018-01-25       Impact factor: 2.960

6.  Trends in Antibiotic Use and Nosocomial Pathogens in Hospitalized Veterans With Pneumonia at 128 Medical Centers, 2006-2010.

Authors:  Barbara E Jones; Makoto M Jones; Benedikt Huttner; Gregory Stoddard; Kevin Antoine Brown; Vanessa W Stevens; Tom Greene; Brian Sauer; Karl Madaras-Kelly; Michael Rubin; Matthew Bidwell Goetz; Matthew Samore
Journal:  Clin Infect Dis       Date:  2015-07-29       Impact factor: 9.079

7.  Does universal active MRSA surveillance influence anti-MRSA antibiotic use? A retrospective analysis of the treatment of patients admitted with suspicion of infection at Veterans Affairs Medical Centers between 2005 and 2010.

Authors:  Makoto Jones; Benedikt Huttner; Molly Leecaster; Angela Huttner; Kavitha Damal; Windy Tanner; Christopher Nielson; Michael A Rubin; Matthew Bidwell Goetz; Karl Madaras-Kelly; Matthew H Samore
Journal:  J Antimicrob Chemother       Date:  2014-08-06       Impact factor: 5.790

8.  Antibiotic prescribing practices in a multicenter cohort of patients hospitalized for acute bacterial skin and skin structure infection.

Authors:  Timothy C Jenkins; Bryan C Knepper; S Jason Moore; Sean T O'Leary; Carla C Saveli; Sean W Pawlowski; Daniel M Perlman; Bruce D McCollister; William J Burman
Journal:  Infect Control Hosp Epidemiol       Date:  2014-08-20       Impact factor: 3.254

9.  Indications and Types of Antibiotic Agents Used in 6 Acute Care Hospitals, 2009-2010: A Pragmatic Retrospective Observational Study.

Authors:  Theodoros Kelesidis; Nikolay Braykov; Daniel Z Uslan; Daniel J Morgan; Sumanth Gandra; Birgir Johannsson; Marin L Schweizer; Scott A Weisenberg; Heather Young; Joseph Cantey; Eli Perencevich; Edward Septimus; Arjun Srinivasan; Ramanan Laxminarayan
Journal:  Infect Control Hosp Epidemiol       Date:  2015-10-12       Impact factor: 3.254

10.  Inpatient Management of Uncomplicated Skin and Soft Tissue Infections in 34 Veterans Affairs Medical Centers: A Medication Use Evaluation.

Authors:  Jesse D Sutton; Ronald Carico; Muriel Burk; Makoto M Jones; XiangMing Wei; Melinda M Neuhauser; Matthew Bidwell Goetz; Kelly L Echevarria; Emily S Spivak; Francesca E Cunningham
Journal:  Open Forum Infect Dis       Date:  2020-01-27       Impact factor: 3.835

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.